Pfizer Shares (Diluted) increased by 190933.3% to 5.7B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.4%, from 5.7B to 5.7B. Over 3 years (FY 2021 to FY 2025), Shares (Diluted) shows relatively stable performance with a 0.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 5.7B | 5.7B | 20M | 5.8B | 5.7B | 5.7B | 4M | 5.7B | 5.7B | 5.6B | 5.7B | 5.7B | 5.7B | 1M | 5.7B | 5.7B | 5.7B | 3M | 5.7B |
| QoQ Change | — | +0.8% | -99.7% | >999% | -0.8% | +0.1% | -99.9% | >999% | -0.2% | -1.2% | +0.9% | -0.0% | +0.2% | -100.0% | >999% | -0.1% | +0.1% | -99.9% | >999% |
| YoY Change | — | — | — | — | +0.6% | -0.1% | -80.0% | -0.5% | +0.0% | -1.3% | -0.5% | -0.3% | +1.0% | — | +0.2% | +0.2% | +0.2% | +200.0% | +0.4% |